Related Image: California Public Pension Crisis: The Ticking Time Bomb, a Full Disclosure Network Cable TV Series |
(Date:12/2/2009)...wire/ -- Proving true the old adage that "The sum ...thodist Hospital Southlake (THHMHS) is partnering ...program to make the holiday season a little bright...combining their efforts to collect unwrapped toys ...ms, culminating in a final event on Tuesday, Dece...
(Date:12/2/2009)...y-six percent of low-income mothers who participat...cated a strong general feeling of distrust of the ...ds men did not prevent them from entering into a m...rmore, the union was often later described by some...ssertions of distrust and insecurity. The results ...
(Date:12/2/2009)...hnology and ASML Receive Innovation Awards in Octo...PRWEB) December 2, 2009 -- ILS Technology, LLC, an...connectivity, today announced that the company and...h awards for technical innovation to the industry....onal Society of Automation (ISA) named ILS Technol...
(Date:12/2/2009)...ec. 2 Watson Pharmaceuti... Federal Trade Commission (FTC) has accepted a pro... Watson,s pending acquisition of privately held Ar... Hart Scott Rodino waiting period, thereby permitt...ties have now obtained all regulatory approvals re...
(Date:12/2/2009)...h., Dec. 2 drugstore.com... of health, beauty, vision and pharmacy products i...in China, India, and Brazil, plus 50 additional co...onal customers can shop for non-prescription healt...tional.drugstore.com with pricing in their local ...
Breaking Medicine News(10 mins):Health News:Texas Health Harris Methodist Hospital Southlake Joins With U.S. Marine Corps Reserves Toys for Tots to Spread Holiday Cheer 2Health News:ILS Technology and Customer ASML Recipients of Industry Recognition Awards 2Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:drugstore.com Continues Global Sales Expansion to More Than 3.5 Billion International Consumers 2...11 Oculus Innovative,Sciences, Inc. (Nasdaq: OCL...ufactures and markets a family of products based u...ounced that the company,s CEO, Hojabr Alimi,is fea... the company,s latest press release., To view ...
...rom First Pivotal Phase 3 Clinical Trial, VALENCI... MNKD ) today announced that it will host an anal...nical results from Phase 3 and,other clinical tria...New York City. To access the live audio broadcast ...
...plier connectivity and experience in healthcare, ...e the use of standards quickl... 11 GHX, LLC has announced,plans to become part o... hospitals and suppliers, along with its,experienc...
... Recently appointed DWC Commissioner Rod Bordelo...ole at the 2008 Texas Workers, Comp Forum, October...Dallas. , Dallas (PRWEB) ...sent a Keynote Address at the upcoming http://www...
... The doctors at Northeastern Eye Institute have ... , (PRWEB) September 11, ... Pennsylvania is proud to announce the opening of ...tients for eye care and eye wear. , , ,The new off...
... Shadow Technology today announced that Faircoun...ad selected Shadow Technology,s IP Call Recording...veral months evaluating a number of different prod...n London, Tampa and Sydney had selected Shadow Tec...
Other Medicine News:Health News:[video] Hojabr Alimi, CEO of Oculus Innovative Sciences, Inc. Discusses Reduction of Planned Expenses on WallSt.net's 3-Minute Press Show 2Health News:MannKind Corporation to Host Webcast Analyst Day September 16, 2008 2Health News:GHX to Become GDSN-certified Data Pool to Accelerate Use of GS1 Standards in Healthcare 2Health News:GHX to Become GDSN-certified Data Pool to Accelerate Use of GS1 Standards in Healthcare 3Health News:Council on Education in Management Announces New Commissioner Rod Bordelon will Present a Keynote Address at the 5th Annual Texas Workers' Comp Forum 2Health News:Northeastern Eye Institute Opens New Office 2Health News:Faircount Media Group Choose "Call-Shadow" for IP Call Recording After Extensive Market Review 2Health News:Faircount Media Group Choose "Call-Shadow" for IP Call Recording After Extensive Market Review 3Health News:Faircount Media Group Choose "Call-Shadow" for IP Call Recording After Extensive Market Review 4(Date:12/2/2009)...E, Md., Dec. 2 Novavax, ...tial results from the first stage of a two-stage p...munogenicity of the company,s 2009 H1N1 virus-like...ax is conducting this study in collaboration with ...ion of the vaccine in Mexico and potentially other...
(Date:12/2/2009)...ORK, Dec. 2 Keryx Biopha...d that the U.S. Food and Drug Administration (FDA)...perifosine), the Company,s novel, potentially firs...he phosphoinositide 3-kinase (PI3K)/Akt pathway, f...yeloma. ,, The Fast Track program of the FDA ...
(Date:12/2/2009)...AM, Ala., Dec. 2 Adults are more...h cancer. For adults 65 and over, the odds of losi...man developing prostate cancer are one in six and ...n nine. Vision loss threatens the overall health ..., depression and inability to complete daily tasks...
Breaking Medicine Technology:NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 1Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease 3B Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver 4745 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 1Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 2Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 3Highlights of Economic and Business Growth in the Tampa Bay Region 28News Briefs 29 52073 4Good News for Seniors 3A California Lowest in Overall Medicare Cost Increases Says MedicareSupplementPlans com 52072 1Good News for Seniors 3A California Lowest in Overall Medicare Cost Increases Says MedicareSupplementPlans com 52072 2... LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - Teva... AB today,announced that data from a 36-week, rand... study demonstrated that an oral 0.6 mg,dose of la...c,resonance imaging (MRI) disease activity by 38 p... addition, there was a favorable,trend towards red...
...d EDSS progression reduced by 40 percent compared,...wire/ -- Bayer HealthCare,Pharmaceuticals announce...tion(1) of Betaseron(R) (interferon beta-1b) treat...multiple sclerosis (MS),can significantly reduce t...asured by the Expanded Disability Status Scale,(ED...
Other Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 2First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 3First of Its Kind Data Show: Immediate Treatment of Early MS,Patients with Betaseron Significantly Delayed Permanent Disability 4...o principal goals of the DJD® II are to allow ...ct the articular surfaces of the elbow and collate...is designed to replicate the elbow's axis of rotat...vents the articular surfaces from damaging each ot...
...E-Fischer External Fixation System is a highly ver...ons ranging from simple fractures to complex recon...as proven its versatility and effectiveness. , ,... following indications: tibia plateau fractures, p...
Hexabrix
Omnipaque®
Medicine Products: